rs201036875
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001572.5(IRF7):c.392G>A(p.Arg131Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000489 in 1,544,066 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001572.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF7 | NM_001572.5 | c.392G>A | p.Arg131Gln | missense_variant, splice_region_variant | 4/11 | ENST00000525445.6 | NP_001563.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000479 AC: 73AN: 152268Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000655 AC: 91AN: 138912Hom.: 0 AF XY: 0.000545 AC XY: 41AN XY: 75298
GnomAD4 exome AF: 0.000491 AC: 683AN: 1391680Hom.: 5 Cov.: 31 AF XY: 0.000516 AC XY: 354AN XY: 686682
GnomAD4 genome AF: 0.000472 AC: 72AN: 152386Hom.: 0 Cov.: 33 AF XY: 0.000496 AC XY: 37AN XY: 74524
ClinVar
Submissions by phenotype
Immunodeficiency 39 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 02, 2022 | IRF7 NM_004031.2 exon 2 p.Arg144Gln (c.431G>A): This variant has not been reported in the literature but is present in 0.1% (20/15292) of Latino alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/11-614799-C-T?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:573866). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 144 of the IRF7 protein (p.Arg144Gln). This variant is present in population databases (rs201036875, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with IRF7-related conditions. ClinVar contains an entry for this variant (Variation ID: 573866). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 18, 2022 | - - |
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.431G>A (p.R144Q) alteration is located in exon 2 (coding exon 2) of the IRF7 gene. This alteration results from a G to A substitution at nucleotide position 431, causing the arginine (R) at amino acid position 144 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
IRF7-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 03, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at